Perhaps unsurprisingly, we’ve spent a lot of time this week at MBS thinking about what makes a successful leadership transition. In the early hours of
As a sector, Healthcare is built on the strengths and commitment of its clinicians, scientists and carers. Like pilots, engineers, designers, lawyers and teachers, these
Who remembers where they were on this day fourteen years ago? I do, because on the morning of 11th May 2010, more than a decade
It has never been more important to build an impactful employer brand. In 2024, candidates are looking for more than a competitive salary package: they’re
The MBS Group is delighted to present the 2024 edition of the Women to Watch in Hospitality, Travel, Leisure and Retail Index, produced in partnership
Patrick Kane’s email signature reads: he/him/disabled. “This isn’t because I want more time to complete tasks, or because I need reasonable adjustments,” he says, “but
Cera launches AI lab to tackle care capacity and boost productivity. Cera has unveiled what it calls the first AI lab dedicated to the care sector, aiming to build and license tools to ease global capacity strains. The company cites AI that predicts risks with over 80% accuracy.
Doctor Care Anywhere embeds Tandem AI to automate clinical documentation at scale. The integration places Tandem’s AI inside Doctor Care Anywhere’s virtual primary care platform to auto-capture consultations and create structured records. It supports around 60,000 consultations a month and aims to cut admin for clinicians.
The Equity Studio backs All Things with multimillion-pound funding to scale. The investment, alongside Access Industries, is targeting growth for the UK’s fastest-growing dairy brand. All Things launched in 2023 with viral butter and added cottage cheese this year, which beat early retail expectations.
Tilray buys Lyphe Group to build integrated UK medical cannabis platform. Tilray Brands has acquired UK-based Lyphe Group to expand Tilray Medical’s presence. Lyphe has dispensed about 150,000 units and treated over 16,000 patients. Tilray says the deal creates its first fully integrated, patient-centric platform.
Pernod Ricard flags travel retail hit as Q3 sales edge higher. The spirits group posted a like-for-like sales rise to €1.95bn, beating expectations, however it now sees full-year organic net sales down 3-4% due to tourism weakness. Travel retail was 6% of sales in 2025 and long-term growth guidance was reaffirmed.
Dunelm lifts Q3 sales but guides full-year profit to lower end. Total sales rose 2.1% to £472m, with digital at 43%. Year-to-date sales grew to £1.4bn. Dunelm expects FY26 pre-tax profit at the lower end of £210-217m amid softer March trading and weaker consumer confidence.
Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.
